Prevalence of SARS-CoV-2 infection in India

2020224 citationsJournal Articlediamond Open Access

Authors

ManojV Murhekar · National Institute of Epidemiology

Tarun Bhatnagar · National Institute of Cancer Prevention and Research

Sriram Selvaraju

Kiran Rade · World Health Organization - India

V. Saravanakumar

Jeromie Wesley Vivian Thangaraj · National Institute of Cancer Prevention and Research

M Santhosh Kumar · National Institute of Cancer Prevention and Research

Abstract

Seroprevalence of SARS-CoV-2 was low among the adult population in India around the beginning of May 2020. Further national and local serosurveys are recommended to better inform the public health strategy for containment and mitigation of the epidemic in various parts of the country.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research COVID-19 epidemiological studies COVID-19 Clinical Research Studies

UN Sustainable Development Goals

Sustainable cities and communities

Publication Details

Published in: The Indian Journal of Medical Research

Volume 152, Issue 1-2, pp. 48-60

DOI: 10.4103/ijmr.ijmr_3290_20

Field-Weighted Citation Impact: 5.79